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COMMENTS TO AUTHORS
This review summarizes well how anti-diabetic agents, especially PPAR activity modulators, can be hypothesized as potential therapeutic approaches for AD. This is an interesting point of view that considers AD as a neurodegenerative disease associated with a diabetic syndrome (commonly named type-3-diabetes). An important question regarding the AD patients that could be clinically managed with anti-diabetic strategies stay undiscussed in this review: when should patients be treated with anti-diabetics in order to obtain the optimal beneficial effect?
